Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1241-1249

  Rafter, Ingalill ^a   Gråberg, Truls ^b   Kotronen, Anna ^c   Strömmer, Lovisa ^b   Mattson, C Mikael ^d   Kim, Ray W ^e   Ehrenborg, Ewa ^d   Andersson, Håkan B ^a   Yki Järvinen, Hannele ^c   Schuppe Koistinen, Ina ^a   Ekblom, Björn ^d   Cotgreave, Ian ^a   Glinghammar, Björn ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MAYO CLINIC   (United States)

Author keywords

Alanine aminotransferase; Biomarkers; Creatine kinase; Liver injury; Skeletal muscle injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE DEHYDROGENASE; ISOENZYME;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD ANALYSIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; EXERCISE; FEMALE; HEPATITIS C; HUMAN; LIVER INJURY; LIVER SURGERY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MUSCULOSKELETAL INJURY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHYSICAL EXERTION; PROTEIN ISOFORMS; YOUNG ADULT;

EID: 84866615267     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1106     Document Type: Article

References (31)

1. Karmen A, Wroblewski F and Ladue JS: Transaminase activity in human blood. J Clin Invest 34: 126-131, 1955.
2. Lindena J, Sommerfeld U, Hopfel C and Trautschold I: Catalytic enzyme activity concentration in tissues of man, dog, rabbit, guinea pig, rat and mouse. Approach to a quantitative diagnostic enzymology, III. Communication. J Clin Chem Clin Biochem 24: 35-47, 1986. (Pubitemid 16154470)
3. Yang RZ, Blaileanu G, Hansen BC, Shuldiner AR and Gong DW: cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase. Genomics 79: 445-450, 2002. (Pubitemid 34211953)
4. Sohocki MM, Sullivan LS, Harrison WR, et al: Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites. Genomics 40: 247-252, 1997. (Pubitemid 27124086)
5. Glinghammar B, Rafter I, Lindstrom AK, et al: Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma. Int J Mol Med 23: 621-631, 2009.
6. DeRosa G and Swick RW: Metabolic implications of the distribution of the alanine aminotransferase isoenzymes. J Biol Chem 250: 7961-7967, 1975.
7. Pette D and Luh W: Constant-proportion groups of multilocated enzymes. Biochem Biophys Res Commun 8: 283-287, 1962.
8. Meton I, Egea M, Fernandez F, Eraso M C and Baanante IV: The N-terminal sequence directs import of mitochondrial alanine aminotransferase into mitochondria. FEBS Lett 566: 251-254, 2004. (Pubitemid 38625967)
9. Swick RW, Barnstein PL and Stange JL: The metabolism of mitochondrial proteins. I. Distribution and characterization of the isozymes of alanine aminotransferase in rat liver. J Biol Chem 240: 3334-3340, 1965.
10. Gubern G, Imperial S, Busquets M and Cortes A: Partial characterization of the alanine aminotransferase isoenzymes from human liver. Biochem Soc Trans 18: 1288-1289, 1990.
11. Gubern G, Imperial S, Busquets M and Cortes A: Subcellular distribution of alanine aminotransferase activity in human liver. Biochem Soc Trans 18: 1287-1288, 1990.
12. Lindblom P, Rafter I, Copley C, et al: Isoforms of alanine aminotransferases in human tissues and serum - differential tissue expression using novel antibodies. Arch Biochem Biophys 466: 66-77, 2007. (Pubitemid 47422249)
13. Neuschwander-Tetri BA and Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219, 2003. (Pubitemid 36538699)
14. Szczepaniak LS, Nurenberg P, Leonard D, et al: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288: E462-E468, 2005. (Pubitemid 40110657)
15. Mattsson CM, Stahlberg M, Larsen FJ, Braunschweig F and Ekblom B: Late cardiovascular drift observable during ultraendurance exercise. Med Sci Sports Exerc 43: 1162-1168, 2011.
16. Berg U, Enqvist JK, Mattsson CM, et al: Lack of sex differences in the IGF-IGFBP response to ultra endurance exercise. Scand J Med Sci Sports 18: 706-714, 2008.
17. Wallberg L, Mikael Mattsson C, Enqvist JK and Ekblom B: Plasma IL-6 concentration during ultra-endurance exercise. Eur J Appl Physiol 111: 1081-1088, 2011.
18. Enqvist JK, Mattsson CM, Johansson PH, Brink-Elfegoun T, Bakkman L and Ekblom BT: Energy turnover during 24 h and 6 days of adventure racing. J Sports Sci 28: 947-955, 2010.
19. Kotronen A, Peltonen M, Hakkarainen A, et al: Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137: 865-872, 2009.
20. Vanhamme L, van den Boogaart A and Van Huffel S: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129: 35-43, 1997. (Pubitemid 127454051)
21. Longo R, Pollesello P, Ricci C, et al: Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5: 281-285, 1995.
22. Miyazaki M, Rosenblum JS, Kasahara Y, Nakagawa I and Patricelli MP: Determination of enzymatic source of alanine aminotransferase activity in serum from dogs with liver injury. J Pharmacol Toxicol Methods 60: 307-315, 2009.
23. Aithal GP, Watkins PB, Andrade RJ, et al: Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89: 806-815, 2011.
24. Giesen PL, Peltenburg HG, de Zwaan C, Janson PC, Flendrig JG and Hermens WT: Greater than expected alanine aminotransferase activities in plasma and in hearts of patients with acute myocardial infarction. Clin Chem 35: 279-283, 1989. (Pubitemid 19075607)
25. Barshes NR, Lee TC, Goodpastor SE, et al: Transaminitis after pancreatic islet transplantation. J Am Coll Surg 200: 353-361, 2005. (Pubitemid 40298969)
26. Pettersson J, Hindorf U, Persson P, et al: Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pharmacol 65: 253-259, 2008. (Pubitemid 351171267)
27. O'Brien PJ, Slaughter MR, Polley SR and Kramer K: Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab Anim 36: 313-321, 2002. (Pubitemid 34785766)
28. Phornphutkul KS, Anuras S, Koff RS and Seeff LB: Causes of increased plasma creatine kinase activity after surgery. Clin Chem 20: 340-342, 1974.
29. Giannini EG, Testa R and Savarino V: Liver enzyme alteration: a guide for clinicians. CMAJ 172: 367-379, 2005. (Pubitemid 40208726)
30. Wichardt E, Mattsson CM, Ekblom B and Henriksson-Larsen K: Rhabdomyolysis/myoglobinemia and NSAID during 48 h ultra-endurance exercise (adventure racing). Eur J Appl Physiol 111: 1541-1544, 2011.
31. Ah YM, Kim YM, Kim MJ, et al: Drug-induced hyperbilirubinemia and the clinical influencing factors. Drug Metab Rev 40: 511-537, 2008.